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Abstract  In  the  assessment  of  lung  cancer,  computed  tomography  guides  the  use  of  bron-
choscopy and  establishes  whether  local  treatment  may  be  appropriate  for  the  NSCLC  or  whether
it is  at  an  advanced  stage.  Percutaneous  biopsy  of  a  lesion  suspected  to  be  a  metastasis  can
provide histological  conﬁrmation,  allowing  staging  to  be  carried  out  at  the  same  time.  The  ini-
tial presentation  depends  on  the  staging  and  histological  type,  ranging  from  an  isolated  nodule
or mass  to  atelectasis  or  obstructive  pneumonia,  isolated  lymph  node  disease  or  isolated  pleural
effusion to  miliary  metastasis  in  tumors  showing  EGFR  mutation.  Tumor  (T)  status  depends  on
tumor size,  distance  from  the  carina,  and  invasion  of  the  chest  wall  and  mediastinal  organs.
PET-CT is  superior  to  CT  in  identifying  lymph  node  invasion  (N2  for  ipsilateral  mediastinal  dis-
ease and  N3  for  contralateral  or  supraclavicular  disease).  As  a  general  rule,  all  contraindications
for surgery  should  be  conﬁrmed  via  histological  examination,  with  the  exception  of  cerebral
metastases.
© 2014  Published  by  Elsevier  Masson  SAS  on  behalf  of  the  Éditions  françaises  de  radiologie.The  diagnosis  of  non-small  cell  lung  cancer  (NSCLC)  requires  histological  conﬁrmation.
However,  imaging,  particularly  computed  tomography,  is  an  important  initial  step,  which
guides  sampling.  The  aim  of  imaging  is  twofold:  to  assess  extension  of  the  disease  and
to  target  the  region  for  sampling  in  order  to  better  evaluate  the  disease  stage  so  that
treatment  can  be  planned.
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focal  ground  glass  areas  distant  from  the  main  lesion  (Fig.  2).
Squamous  cell  carcinomas  (Fig.  3)  are  usually  cen-
tral,  cavitating  and  necrotic  in  appearance  compared  to
Figure 1. Chest CT, parenchymal window. Left lower lobe conso-
lidation with air bronchogram and anterior lucencies, ground glass
is also present posteriorly. These ﬁndings are consistent with an
adenocarcinoma.
Figure 2. Chest CT, parenchymal window. Left lower lobe conso-28  
maging methods
omputed  tomography  is  the  ﬁrst-line  imaging  investigation
n  NSCLC. 18FDG  PET-CT  is  only  considered  secondarily,  for
atients  who  may  be  eligible  for  curative  treatment,  accord-
ng  to  the  latest  INCa  recommendations  [1].
CT  should  be  performed  before  bronchoscopy,  as  this
mproves  the  performance  of  the  bronchoscopy.
Multislice  CT  images  should  be  reconstructed  as  con-
iguous  1-mm  sections  to  obtain  high  quality  multiplanar
eformations  and  followed  by  MIP  (maximum  intensity  pro-
ection)  post  processing  for  the  detection  of  small  nodules
istant  from  the  main  lesion  [2],  in  addition  to  native
mages.
The  acquisition  should  begin  in  the  lower  neck  region
nd  include  the  supraclavicular  regions  to  avoid  missing  lym-
hadenopathy  which  would  deﬁne  N3  disease.
Imaging  is  continued  down  to  the  abdominal  level  (or
ven  the  pelvis)  to  assess  the  liver  parenchyma  and  adrenal
lands.  Post-contrast  images  of  the  brain  provide  an  initial
ssessment  of  the  metastatic  spread.  Up  to  60%  of  patients
iagnosed  from  clinical  symptoms  already  have  metastatic
isease  [3].  All  CT  images  should  also  be  examined  using
one  windowing  to  detect  potential  metastasis.
Iodinated  contrast  administration  improves  the  detec-
ion  of  enlarged  lymph  nodes,  especially  in  the  hilar  regions
nd  in  the  aorto  pulmonary  window.  Acquisition  of  tho-
acic  images  should  ideally  start  during  the  arterial  phase
f  enhancement,  30  seconds  after  the  start  of  injection  and
t  the  portal  phase  for  the  abdomen,  to  evaluate  the  liver
arenchyma.  Post-contrast  imaging  shows  whether  lymph
odes  are  homogeneous  or  necrotic  in  structure.
The  arterial  phase  is  used  to  examine  the  relationships
etween  the  tumor  and  the  vascular  and  cardiac  structures
nd  to  identify  any  pulmonary  embolism,  as  malignancy  is  a
redisposing  factor  for  venous  thromboembolic  disease.
The  aim  of  initial  imaging  is  to  establish  whether  the
SCLC  is  localized  and  potentially  responsive  to  a local
reatment  (curative  surgical  resection  or  combined  radio-
hemotherapy),  or  whether  the  disease  is  at  an  advanced
tage,  requiring  medical  treatment.  If  the  disease  is  at  an
dvanced  stage,  the  tumor  targets  need  to  be  deﬁned  in
rder  to  monitor  the  patient  on  chemotherapy.  CT  can  be
sed  to  assess  the  likelihood  of  obtaining  histology  from
ronchoscopy,  which  is  high  if  the  lesion  is  proximal  and
ow  if  it  is  peripheral  (34%  for  peripheral  lesions  under
 cm  in  size)  [4]  or  to  guide  lymph  node  needle  aspirates
ither  by  unguided  transbronchial  biopsy  or  endobronchial
ltrasound-guided  ﬁne  needle  aspiration.  If  a  potentially
etastatic  lesion  is  detected  in  a  site  accessible  to  nee-
le  aspiration,  this  procedure  may  be  suggested  in  order  to
btain  both  histological  conﬁrmation  and  for  staging  pur-
oses  [5],  thus  preventing  an  unnecessary  biopsy  of  the
rimary  lesion.
he different presentations of NSCLChe  presentation  of  NSCLC  varies  depending  on  its  stage
nd  histological  type.  It  may  be  presented  as  an  isolated
odule  or  mass,  which  is  more  likely  to  be  peripheral  in
he  case  of  adenocarcinoma.  The  presence  of  an  ectatic
l
g
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ir  bronchogram  (bubble-like  lucencies)  and  ground  glass
omponents  suggest  adenocarcinoma  (Fig.  1).  Mucinous
denocarcinomas  have  a pneumonia-like  presentation  and
re  often  multifocal  as  a  result  of  tumor  dissemination  due
o  the  bronchogenic  spread  of  mucin  accompanied  by  tumor
ells.  Considerable  attention  should  therefore  be  paid  to  anyidation representing a mucinous adenocarcinoma, multiple ground
lass nodules are seen distant from the main lesion, reﬂecting bron-
hogenic spread of the tumor.
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Figure 3. a: chest CT parenchymal window; b: chest CT, mediastinal window. Cavitating left upper lobe lesion representing a squamous cell
carcinoma. There is intense contrast enhancement in the extra-pleural tissues formally deﬁning chest wall T3 status, although no osteolysis
is present. This disease does not contraindicate surgical resection which should be extended to the wall. Lymph nodes of normal size are
present in stations 5 and 6 (radiologically N0). Cavitating left upper lobe mass representing a squamous cell carcinoma. The thickening
mato
a
t
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iof the interlobular septa anterior to the tumor may reﬂect carcino
particularly if the necrotic tumor is super-infected.
adenocarcinomas,  although  in  practice,  there  is  no  reliable
method  to  differentiate  between  the  two.
NSCLC  can  be  presented  in  other  ways  such  as  atelectasis
or  obstructive  pneumonia  (Fig.  4),  mediastinal  lymph  node
disease  with  no  identiﬁable  primary  lesion  in  the  lung  or  an
isolated  malignant  pleural  effusion.  The  initial  presentation
as  ﬂorid  miliary  metastatic  disease  is  relatively  uncommon
Figure 4. Chest CT, mediastinal window, coronal reformation.
Tumor in the left upper lobe bronchus (squamous cell), over 2 cm
from the carena (T2), causing atelectasis of the whole left lung
and therefore T3 status. The left pleural effusion is reactive to the
atelectasis. The patient underwent left pneumonectomy. Histolog-
ical examination concluded that the patient was pT3N1 status, i.e.
stage IIIA.
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msis lymphangitis although may also simply reﬂect lymphatic stasis
nd  suggests  EGFR  (epithelial  growth  factor  receptor)  muta-
ion  [6,7]  (Fig.  5).
In cases  presenting  as  an  isolated  lung  nodule,  signs  sug-
esting  malignancy  are  that  the  nodule  is  over  a  centimeter
n  size,  has  spiculated  outlines,  a  lack  of  fatty  content  and
articularly,  persistence  or  progression  on  two  successive
maging  investigations  [8].
Pancoast  tumors  have  a  speciﬁc  presentation,  with
requent  delayed  diagnosis  as  they  may  present  as  cervico-
acial  neuralgia  which  are  usually  initially  assessed  by
ervical  or  scapular  imaging.
The  apex  of  the  lung  is  a  difﬁcult  region  to  study
ith  computed  tomography  because  of  possible  confusion
igure 5. Chest CT, parenchymal window. Appearances of ﬂorid
iliary metastatic disease in a non-smoking, 72-year-old patient
ho also has a spiculated lesion in the left upper lobe. Percuta-
eous aspiration of the left upper lobe lesion diagnosed a TTF1+
denocarcinoma with an EGFR (epithelial growth factor receptor)
utation.
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etween  the  scalene  muscles  and  an  inﬁltrating  process  or
ymphadenopathy  and  because  of  artefacts  caused  by  the
houlders.  MR  provides  a  better  assessment  of  tumor  exten-
ion  into  the  foramina  and  vertebral  bone  in  posterior  apical
umors  [9].
ommon mistakes in interpreting
ppearances of tumor extension
ommon mistakes in interpretation
he  likelihood  of  malignancy  increases  with  tumor  size,
lthough  some  inﬂammatory  and  infectious  lesions  can
imic  tumors  in  patients  who  do  not  necessarily  have  symp-
oms  of  infection.  It  is  essential,  therefore,  to  examine  serial
mages  and  to  compare  the  size  of  the  suspicious  lesion  on
he  initial  CT  and  on  the  pre-needle  biopsy  CT  or  PET-CT.  Typ-
cally,  non-solid  lesions  resolve  spontaneously  in  31  to  70%
f  cases  [10],  this  can  also  occur  with  solid  lesions  (Fig.  6).
hese  two  imaging  investigations  should  be  performed  close
ogether  (3  to  4  weeks)  in  order  to  prevent  genuine  tumors
rom  progressing.
Another  classic  common  error  is  due  to  lipoid  pneumo-
ia  as  it  can  present  as  a  pseudomalignant  spiculated  lesion
nd  is  often  hyper-metabolic  on  PET-CT  because  of  the  sur-
ounding  inﬂammatory  reaction.  The  key  diagnostic  ﬁnding
s  the  appearance  of  fat  attenuation  within  the  lesion,  which
s  never  seen  in  NSCLC.
(
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igure 6. a: computed tomography section from the PET-CT scan. The
eft Nelson’s area found in a male smoker investigated for cough with no h
f the lesion. The lesion has resolved considerably and the needle aspir
ltimately disappeared completely without treatment; c: on PET-CT theM.-P.  Revel  et  al.
umor extension
ocoregional  (T3  or  T4)
leura  and  chest  wall
ontact  alone  is  insufﬁcient  to  diagnose  invasion,  which  is
onﬁrmed  from  rib  osteolysis  or  extension  to  the  soft  tis-
ues  of  the  chest  wall  (Fig.  3a).  Extension  to  the  mediastinal
at  implies  that  the  mediastinal  pleura  (parietal  pleura)  has
een  breached  and  therefore  indicates  T3  status,  whereas
reach  of  a ﬁssure  (visceral  pleura)  is  classiﬁed  as  T2.
Pleural  disease  distant  from  the  tumor  conﬁrmed  from
odular  enhancement  of  the  pleura  should  be  considered
o  be  a metastatic  disease  (M1a  in  the  2009  classiﬁca-
ion)  although  no  conclusion  can  be  drawn  from  an  isolated
leural  effusion.  Radiologists  should  be  aware  of  the  appear-
nces  of  dry  pleural  dissemination  [11].
rachea  and  bronchi
ecretions  which  mobilize  on  coughing  and  on  changing  posi-
ion,  and  which  contain  air  bubbles  are  not  due  to  tumor
nﬁltration,  which  appears  as  a  ﬁxed  thickening.  The  dis-
ance  from  the  carina  and,  particularly,  the  peribronchial
istance  (Fig.  7),  should  be  measured  on  CT  as  bronchoscopy
nly  visualizes  endobronchial  disease.
orta  and  supra-aortic  vessels,  superior  vena  cava
T4)
ontact  alone  does  not  predict  invasion,  which  can  only
e  formally  diagnosed  if  the  whole  vessel  circumference  is
ncased  in  tumor  or  if  intraluminal  tumor  is  present  within
 PET-CT was performed for assessment of an irregular mass in the
istory of infection; b: reassessment CT before percutaneous biopsy
ate was delayed. This was therefore a non-malignant lesion which
 lesion is highly hyper-metabolic (Fig. 3b).
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Figure 7. Enhanced CT in the mediastinal window. Right upper
lobe lesion stenosing the ventral segmental bronchus. The report
should include the ﬁnding that in the extrabronchial region the
lesion comes to within less than 2 cm from the carena (T3). Lym-
Figure 9. Enhanced CT in the mediastinal window. Right Upper
lobe tumor inﬁltrating the mediastinal fat in contact over 180 per-
cent with the superior vena cava but with a preserved fatty line
(T3). Bulky lymphadenopathy in station 4R, associated with bilateral
enlarged axillary lymph nodes on a background of chronic lymphoid
leukemia (LLC). A small right pleural effusion is present remote
from the lesion. In this case the lesion is classiﬁed as cT3NxMx, as
n
o
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r
w
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a
L
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pphadenopathy is also present in station 4R (N2). The report should
therefore provide a radiological conclusion of cT3N2.
the  vessel  lumen.  Contact  of  less  than  90◦ or  3  cm  sug-
gests  resectability  [12].  It  is  essential  not  to  contraindicate
surgery  without  substantiation,  and  if  the  least  doubt  exists,
then  surgical  exploration  may  answer  this  question  (Fig.  8).
Preservation  of  a  fatty  line  suggests  resectability  (Fig.  9).
Esophagus  (T4)
Isolated  invasion  of  the  esophagus  is  rare  and  difﬁcult  to
diagnose  on  computed  tomography.  Endoscopic  ultrasound
is  the  best  technique  if  uncertainty  exists.
Left  atrium  (T4)
The  left  atrium  can  be  invaded  via  one  of  the  pulmonary
veins  (Fig.  10)  producing  a  hypodense  lesion  within  the
cavity  which  contrasts  with  the  intense  enhancement  of  the
rest  of  the  atrial  cavity.Vertebrae  (T4)
There  is  no  doubt  of  invasion  if  an  obvious  lytic  lesion  is
seen.  MR  is  useful  for  cases  of  limited  cortical  erosion.
a
r
s
Figure 8. Enhanced chest CT in the mediastinal window, axial (a) and 
with over 90 percent of the left subclavian artery and particularly with t
with ﬂattening the dome of the aortic arch. These ﬁndings suggest inop
the thoracotomy. In this case, exploratory thoracotomy conﬁrmed that to status can be inferred about the lymph node disease (Nx) in view
f the LLC, or about the pleura (Mx).
T3  status  is  not  a  contraindication  to  surgery.  In  T4  dis-
ase,  the  decision  depends  on  whether  or  not  the  lesion  is
esectable  or  not,  which  may  remain  uncertain  on  imaging
ithout  the  additional  use  of  MR  as  well  as  CT  [13],  with  the
xception  of  bony  extensions.
MR  is  also  better  at  distinguishing  between  tumor  and
telectasis  [14]  (Fig.  10).
ymph  nodes
he  criterion  used  to  deﬁne  mediastinal  lymph  node  involve-
ent  is  a  short  axis  of  10  mm  or  more  (Fig.  7).  It  is  important
o  remember  the  limitations  of  this  criterion  and  that  com-
uted  tomography  does  not  perform  well  in  the  nodal  staging
s  it  can  produce  both  false  negative  and  false  positive
esults,  particularly  in  obstructive  pneumonia.  There  are  no
ize  criteria  for  hilar  lymph  nodes.  Overall,  the  sensitivity
coronal (b) sections. Tumor inﬁltrating the mediastinum in contact
he top of the aortic arch. A minor deformity is present at this site
erable T4 status and the patient was therefore informed prior to
he lesion was not resectable.
732  M.-P.  Revel  et  al.
Figure 10. Chest MR, T2 weighted axial view (a) and coronal MR angiography (TOF) sequence (b). The right lower lobe tumor is of
intermediary signal on the T2 weighted image (a), greater than the signal from the atelectasis. Small bilateral pleural effusion, very
hyperintense on T2 weighted imaging. The tumor is invading the left atrium (T4) via the right inferior pulmonary vein with a hypointense
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mntra-atrial bud (b) on the coronal MR angiogram view, contrasting 
nd  speciﬁcity  of  computed  tomography  were  reported  to  be
1%  and  79%,  respectively  in  a  meta-analysis  of  39  studies
15].
xtra-thoracic  metastasis  (M1b  status)
drenal  glands:  because  of  the  high  prevalence  of  adrenal
ncidentalomas,  an  adrenal  mass  should  be  considered  a
riori  to  be  metastatic  in  a  patient  with  NSCLC.  If  pre-
ontrast  images  are  available,  an  attenuation  of  less  than
0  HU  is  the  best  indicator  in  favor  of  a  benign  lesion  [16].
n  other  situations  or  if  the  unenhanced  attenuation  is  over
0  HU,  characterization  is  based  on  the  absolute  or  rela-
ive  washout  effect,  in-phase  and  out  of  phase  MR  signal  or
etabolic  activity  on  PET-CT  [17].  The  lesion  requires  his-
ological  conﬁrmation  if  it  is  the  only  potentially  metastatic
ite.
For  liver,  bone  and  cerebral  metastasis  utilize  the  diag-
ostic  criteria  that  apply  to  other  cancers.
Except  for  cerebral  metastases,  any  contraindication  to
urgery  should  be  conﬁrmed  histologically,  particularly  if
he  imaging  ﬁndings  are  not  formal  (potential  N3,  isolated
drenal  hypermetabolism  on  PET-CT).
If  a  single  cerebral  metastasis  is  seen  on  CT  and  it  is
ccessible  to  surgery  or  stereotactic  radiotherapy,  MR  is
equired  to  ensure  that  there  are  no  other  lesions.
NM classiﬁcation
he  TNM  classiﬁcation  was  revised  in  2009  [18—21],  with
hanges  regarding  the  primary  tumor,  T,  the  metastases,  M
nd  the  topographic  criteria  for  lymph  nodes.
 Status
he  tumor  is  classiﬁed  as  T1a,  T1b,  T2a  or  T2b,  depen-
ing  on  whether  its  maximal  diameter  measures  2,  3,  5,  or
 cm,  respectively  and  T3  if  it  is  larger  than  7  cm.  Atelec-
asis  and  obstructive  pneumonia  are  classiﬁed  as  T2  and
3,  respectively  depending  on  whether  they  are  lobar  or
ight  bilobar  or  involve  the  whole  lung.  The  distance  to  the
arina  should  be  measured.  The  tumor  is  graded  T2,  T3  or
a
e
s
sthe hyperintense blood signal.
4  depending  on  whether  this  distance  is  over  2  cm,  under
 cm  or  zero  with  invasion  of  the  carina.  Satellite  nodules
n  the  same  lobe,  an  ipsilateral  non-primary  tumor  lobe  or
 contralateral  lobe  deﬁne  stages  T3,  T4  and  M1a,  respec-
ively  if  they  are  malignant  and  of  the  same  histological  type
s  the  primary  lesion.  The  possibility  of  a  synchronous  and
ccasionally  also  curable  cancer  (with  different  histology)
hould  be  considered.
Vertebral,  central  vessel  or  cardiac  extension  deﬁnes
tage  T4  (Figs.  8  and  10).
 Status
he  2009  classiﬁcation  grouped  mediastinal  lymph  node
egions  into  7  stations:
supraclavicular:  (1R  et  1L);
superior:  (2  R,  2L,  3A,  3P,  4R:  barety,  4L:  paratracheal  G);
aortopulmonary  (5  aortopulmonary  and  6  para-aortic  or
phrenic);
subcarinal  (7);
inferior  (8:  paraesophageal,  9:  of  the  inferior  pulmonary
ligament);
hilar  and  interlobar  (10  and  11);
peripheral  (12  to  14).
Lymphadenopathy  with  short  axis  of  more  than  1  cm
re  described  as  potential  N1  disease  (hilum),  N2  disease
ipsilateral  mediastinum)  or  N3  disease  (Contralateral  medi-
stinum  or  supraclavicular).
In  the  supraclavicular  region,  the  middle  of  the  trachea
eﬁnes  right  and  left  sides  whereas  in  the  paratracheal
tation  (stations  2  and  4),  the  left  edge  of  the  trachea
emarcates  the  right  and  left  sides.
 Status
he  2009  revision  distinguishes  between  intrathoracic
etastases  (contralateral  nodule,  malignant  pleural  disease
nd  malignant  pericardial  inﬁltration)  classiﬁed  as  M1a  and
xtra-thoracic  metastases  (adrenal,  liver,  bone,  brain)  clas-
iﬁed  as  M1b,  as  the  5-year  survival  rate  differs  in  these  two
ituations.
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Staging
It  is  particularly  important  to  deﬁne  the  TNM  status  radio-
logically  (Appendix  A).  The  resulting  staging  which  follows
on  from  this  may  be  made  by  the  physician,  particularly  as
M  status  can  only  be  established  after  a  PET-CT  in  diseases
which  appear  to  be  localized  on  CT.
N2  status  deﬁnes  stage  IIIA  for  T1  to  T3  tumors  and  stage
IIB  for  T4  tumors.
N3  status  deﬁnes  stage  IIIB  (inoperable),  regardless  of  T
status.
The  presence  of  metastases  deﬁnes  stage  IV  regardless
of  T  and  N  status.
TAKE-HOME  MESSAGES
• Inoperability  should  only  be  conﬁrmed  on  formal
evidence,  vertebral,  cardiac,  carinal  invasion,
circumferential  vascular  disease  or  endovascular
extension.
• Chest  wall  extension  (T3)  (rib  osteolysis,  extra-
pleural  extension)  is  not  a  contra-indication  to
surgery.
• A  contralateral  nodule  should  not  be  deemed  to  be
secondary  without  histological  evidence  that  it  is
metastatic.
• Only  demonstration  of  pleural  nodules  indicates
pleural  carcinomatosis,  i.e.  stage  M1a.
• Enlarged  mediastinal  lymph  nodes  may  only  be
reactive  in  obstructive  pneumonia.
Clinical case
Quiz  1
Clinical  details:  this  is  a  69-year-old  smoker  with  cough
and  deterioration  in  general  status  (Fig.  11).
Figure 11. Initial CT performed with contrast enhancement.
Q
1
2
3
4
A
A
a
b
d
A
a 733
uestions
.  What  is  the  T  status  of  the  tumor?
a.  The  tumor  is  at  least  T2.
b.  The  tumor  is  at  least  T3.
c.  The  tumor  is  at  least  T4.
d.  Video-thoracoscopy  is  required  to  establish  this.
.  What  is  the  N  status  of  the  tumor?
a.  The  tumor  is  at  least  N2.
b.  The  tumor  is  N3.
c.  Enlarged  lymph  nodes  are  present  in  stations  4L  and
5.
d.  Enlarged  lymph  nodes  are  present  in  stations  4L  and
6.
.  Should  initial  mediastinoscopy  be  suggested?
.  What  further  imaging  investigations  should  be  per-
formed?
a.  Liver  ultrasound.
b. Bone  scintigraphy.
c. A  cerebral  MR.
d.  PET-CT.
nswers
nswer  1
.  The  tumor  is  at  least  T2:  true.  Lobar  atelectasis  is
present  (in  the  left  upper  lobe)  and  the  tumor  is  there-
fore  at  least  T2.
.  The  tumor  is  at  least  T3:  false.  To  be  classiﬁed  as  T3,  one
of  the  following  conditions  needs  to  be  met:
•  Size  over  7  cm:  this  cannot  be  formally  stated  from  this
single  section;
•  Chest  wall  invasion:  the  peripheral  opacity  is  an
atelectatic  lung  which  enhances  more  intensely  than
the  tumor  itself  and  non-malignant  parenchyma  is
therefore  in  contact  with  the  chest  wall;
• Atelectasis  or  obstructive  pneumonia  of  the  entire  lung:
in  this  case,  it  only  involves  one  lobe;
•  Satellite  tumor  nodule  (same  histology)  in  the  same
lobe:  this  can  only  be  assessed  histologically  after
examination  of  the  lobectomy  specimen.
c.  The  tumor  is  at  least  T4:  false.  To  be  classiﬁed  as  T4,  one
of  the  following  conditions  would  need  to  be  met:  inva-
sion  of  the  carina  or  vascular  structures  (superior  vena
cava,  aorta,  main  pulmonary  arteries),  esophagus  or  a
vertebra:  the  tumor  is  distant  from  all  these  structures;
satellite  tumor  nodule  (same  histology)  in  a  different
lobe  (left  lower  lobe):  this  is  not  seen  here.
.  Video-thorascopy  is  required  for  further  details:  false.
For  the  reasons  described  above,  the  lesion  can  be
deﬁned  as  T2  and  there  are  no  criteria  to  consider  it
to  be  T3  or  T4.
nswer  2
.  The  tumor  is  at  least  N2:  false.  The  lymph  nodes  are
increased  in  size  (short  axis  considerably  more  than
one  centimeter)  but  they  can  only  be  reactive  to  the
obstructive  pneumonia.  Lymph  node  size  is  a very  poor
criterion  for  tumor  invasion  in  atelectasis/obstructive
pneumonia.  In  this  case,  PET-CT  would  be  useful  to
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ascertain  whether  the  lymph  nodes  were  not  hyper-
metabolic,  allowing  initial  surgery  if  the  patient  was
operable  depending  on  results  of  staging  and  functional
evaluation.  If  the  lymph  nodes  were  hyper-metabolic,
an  initial  mediastinoscopy  in  station  4L  would  be
required  to  conﬁrm  or  exclude  N2  status.  N2  status
would  require  neoadjuvant  chemotherapy  and  not  ini-
tial  surgery.  Station  6  (phrenic  or  ascending  aorta)  is  not
accessible  by  mediastinoscopy.
.  The  tumor  is  N3:  false.  N3  status  is  deﬁned  by  contrala-
teral  mediastinal  (or  hilar)  or  supraclavicular  lymph  node
disease.
c.  Enlarged  lymph  nodes  are  present  in  stations  4L  and  5:
false.  Enlarged  lymph  nodes  are  present  in  4L  station
(Left  of  the  arterial  ligament,  not  seen  here,  but  aligned
with  the  internal  aspect  of  the  left  pulmonary  artery)
and  in  station  6,  ascending  aorta  or  phrenic.
.  Enlarged  lymph  nodes  are  present  4L  and  6:  true.  Cf.
comment  above.
nswer  3
o,  only  if  the  PET-CT  shows  hyper-metabolic  activity.  The
egative  predictive  value  of  PET-CT  is  high  if  lymph  nodes
re  enlarged.
nswer  4
a.  Liver  ultrasound:  false.  The  metastatic  status  assessment
is  performed  using  PET-CT,  brain  excluded.
.  Bone  scintigraphy:  false.  The  metastatic  status  assess-
ment  is  performed  using  PET-CT,  brain  excluded.
c.  Cerebral  MR:  True.  PET-CT  does  not  investigate  the  brain.
.  PET-CT:  true.  PET-CT  is  recommended  for  staging  assess-
ment  in  patients  who  have  localized  disease  on  computed
tomography.
inal comment
his  case  is  a  T2  tumor  causing  atelectasis/obstructive  pneu-
onia  of  the  left  upper  lobe.  PET-CT  showed  no  mediastinal
r  extra-thoracic  hypermetabolism,  the  cerebral  investi-
ation  was  negative  and  surgical  resection  was  therefore
ossible.  The  message  here  is  that  potential  false  positives
n  mediastinal  lymph  node  assessment  when  lobar  or  pul-
onary  atelectasis  is  present  should  be  guarded  against.
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Quiz  2
Clinical  history:  Mr  F,  a  58-year-old  man  with  two
pisodes  of  hemoptysis  (Fig.  12).
uestions
.  What  suggests  the  upper  lobe  lesion  malignancy?
a.  Its  spiculated  appearance.
b.  Its  size  is  superior  to  1  cm.
c.  Its  central  location.
d.  Its  cavitating  appearance  with  thickened  walls.
.  Can  its  radiological  status  be  deﬁned  as  N0?
.  The  distant  disease  assessment  is  negative  and  the  spi-
culated  lesion  measures  3.4  cm  in  size.  The  tumor  can  be
classiﬁed  as:
a. cT2N0M0.
b.  cT3N0M0.
c.  cT2aN0M0.
d.  cT2bN0M0.
.  Cavitating  tumors  may  be  complicated  by  Aspergillus
colonization:  true  or  false?
nswers
nswer  1
a.  The  spiculated  appea-
rance:  true.  The  spiculated  appearance  is  highly
suggestive  of  a malignancy.
.  Its  size  is  superior  to  1  cm:  true.  The  likelihood  of  malig-
nancy  increases  with  size  from  1%  under  5  mm  to  85%
over  2  cm.
c.  Central  site:  false.  Adenocarcinomas  tend  more  to  be
peripheral.
.  The  cavitating  appearance  with  thick  walls:  true.  Infec-
tious  nodules  can  be  cavitating  but  generally  have  a  thin
wall.  The  cavitating  necrotic  appearance  is  more  com-
mon  in  squamous  cell  carcinomas.
nswer  2
rue.  Lymph  nodes  are  seen  in  station  5  (outside  of  the  arte-
ial  ligament)  and  in  station  6,  although  these  are  of  normal
orphology,  oval  in  shape  with  a  short  axis  well  below  1  cm
n  size.  These  should  not  be  referred  to  as  lymphadenopathy.
 mediastinal (b) windows.
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Answer  3
a.  cT2N0M0:  false  the  2009  classiﬁcation  subdivides  T2
tumors  (over  3  cm)  into  two  T2  subgroups:  T2  a of  up
to  5 cm  and  T2  b  over  5  cm  and  up  to  7  cm.
b.  cT3N0M0:  false  only  tumors  over  7  cm  are  classiﬁed  as
T3.
c.  cT2aN0M0:  true  cf.  answer  1.
d.  cT2bN0M0:  false  cf.  answer  1.
Answer  4
4:  True.  An  aspergilloma  may  develop  in  a  cavitating  tumor
if  it  progresses  chronically.  The  typical  appearance  is  that
of  a  fungus  ball,  with  a  rounded  opaciﬁcation  which  more  or
T
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ess  ﬁlls  the  cavity,  with  the  exception  of  a  clear  crescent
f  peripheral  gas  (air  crescent  sign).
inal comment
his  was  a  T2a  N0M0  left  upper  lobe  squamous  cell  carci-
oma  which  was  cavitating  without  Aspergilloma.  Extension
o  the  pleural  ﬁssure  does  not  change  its  T2  status.he  authors  declare  that  they  have  no  conﬂicts  of  interest
oncerning  this  article.
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